Russell Hope

7.9k total citations · 1 hit paper
109 papers, 3.5k citations indexed

About

Russell Hope is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Russell Hope has authored 109 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 39 papers in Infectious Diseases and 34 papers in Molecular Medicine. Recurrent topics in Russell Hope's work include Antibiotic Resistance in Bacteria (34 papers), Antibiotic Use and Resistance (24 papers) and Antimicrobial Resistance in Staphylococcus (19 papers). Russell Hope is often cited by papers focused on Antibiotic Resistance in Bacteria (34 papers), Antibiotic Use and Resistance (24 papers) and Antimicrobial Resistance in Staphylococcus (19 papers). Russell Hope collaborates with scholars based in United Kingdom, Japan and Netherlands. Russell Hope's co-authors include Naresh Magan, David M. Livermore, David Aldred, Michel Doumith, Neil Woodford, Rosy Reynolds, Victoria Cairns, G. Brick, Alan P. Johnson and Shazad Mushtaq and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Russell Hope

106 papers receiving 3.4k citations

Hit Papers

Hospital admission and emergency care attendance risk for... 2021 2026 2022 2024 2021 100 200 300

Peers

Russell Hope
Alan McNally United Kingdom
Nicole Stoesser United Kingdom
Wil H. F. Goessens Netherlands
Russell Hope
Citations per year, relative to Russell Hope Russell Hope (= 1×) peers Beiwen Zheng

Countries citing papers authored by Russell Hope

Since Specialization
Citations

This map shows the geographic impact of Russell Hope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Hope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Hope more than expected).

Fields of papers citing papers by Russell Hope

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Hope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Hope. The network helps show where Russell Hope may publish in the future.

Co-authorship network of co-authors of Russell Hope

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Hope. A scholar is included among the top collaborators of Russell Hope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Hope. Russell Hope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blum, Maxim, Jeroen Geurtsen, Eva Herweijer, et al.. (2025). Epidemiology of invasive Escherichia coli disease in adults in England, 2013–2017. Epidemiology and Infection. 153. e4–e4. 1 indexed citations
2.
Quan, T. Phuong, David W. Eyre, Daniel J. West, et al.. (2025). Timeliness of a potential automated system for national surveillance of healthcare-associated infections in England. Journal of Hospital Infection. 161. 10–12. 1 indexed citations
3.
Reynolds, Rosy, Shazad Mushtaq, Russell Hope, et al.. (2025). Antimicrobial resistance among Gram-positive agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019. Journal of Antimicrobial Chemotherapy. 80(Supplement_4). iv22–iv35. 1 indexed citations
5.
Reynolds, Rosy, Shazad Mushtaq, Olisaeloka Nsonwu, et al.. (2025). The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: methods and limitations. Journal of Antimicrobial Chemotherapy. 80(Supplement_4). iv7–iv21. 5 indexed citations
6.
7.
Todkill, Daniel, Theresa Lamagni, Richard Pebody, et al.. (2024). Persistent elevation in incidence of pneumonia in children in England, 2023/24. Eurosurveillance. 29(32). 4 indexed citations
8.
Flannagan, Joe, Dimple Chudasama, Russell Hope, et al.. (2023). Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks. Epidemiology and Infection. 151. e191–e191. 1 indexed citations
9.
Paranthaman, Karthik, Allegra Wilson, Neville Q. Verlander, et al.. (2023). Trends in coagulase-negative staphylococci (CoNS), England, 2010–2021. Access Microbiology. 5(6). 5 indexed citations
10.
Collin, Simon M., Rebecca Guy, M. Ganner, et al.. (2023). Is Panton–Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community-acquired Staphylococcus aureus bacteraemia?. Journal of Medical Microbiology. 72(4). 3 indexed citations
12.
Harman, Katie, Sophie Nash, Harriet Webster, et al.. (2023). Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England. Influenza and Other Respiratory Viruses. 17(5). e13150–e13150. 14 indexed citations
13.
Webster, Harriet, Tommy Nyberg, Mary Sinnathamby, et al.. (2022). Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England. Nature Communications. 13(1). 6053–6053. 18 indexed citations
14.
Bhattacharya, Alex, Simon M. Collin, James Stimson, et al.. (2021). Healthcare-associated COVID-19 in England: A national data linkage study. Journal of Infection. 83(5). 565–572. 39 indexed citations
15.
Aliabadi, Shirin, Elizabeth Beech, Elita Jauneikaite, et al.. (2021). Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013–18): a quasi-experimental, ecological, data linkage study. The Lancet Infectious Diseases. 21(12). 1689–1700. 36 indexed citations
16.
Toleman, Michelle S., Sandra Reuter, Dorota Jamrozy, et al.. (2019). Prospective genomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) associated with bloodstream infection, England, 1 October 2012 to 30 September 2013. Eurosurveillance. 24(4). 18 indexed citations
17.
Mushtaq, Shazad, et al.. (2013). Activity of BAL30072 alone or combined with  -lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters. Journal of Antimicrobial Chemotherapy. 68(7). 1601–1608. 30 indexed citations
18.
Dhanji, H., Michel Doumith, Paul J. Rooney, et al.. (2010). Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum  -lactamases in nursing homes in Belfast, UK. Journal of Antimicrobial Chemotherapy. 66(2). 297–303. 51 indexed citations
19.
Livermore, David M., Russell Hope, Shazad Mushtaq, & M. Warner. (2008). Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers. Clinical Microbiology and Infection. 14. 189–193. 51 indexed citations
20.
Hope, Russell, et al.. (2006). Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 59(1). 110–113. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026